Richard Meier
About Richard Meier
Richard Meier is a Senior Manager of Biostatistics at Bristol Myers Squibb with a strong background in biostatistics and bioinformatics, and over a decade of research experience in the US and Germany.
Current Position at Bristol Myers Squibb
Richard Meier is currently a Senior Manager in Biostatistics at Bristol Myers Squibb. He joined the company in March 2021. In this role, Richard leverages his extensive expertise in both biostatistics and bioinformatics to contribute to the company's research and development efforts.
Previous Roles at University of Kansas Medical Center
Richard Meier held multiple positions at the University of Kansas Medical Center. He was a Postdoctoral Researcher from 2020 to 2021 and a Graduate Research Assistant from 2015 to 2020. Prior to that, he worked as a Research Scholar from 2013 to 2014. These roles allowed him to deepen his skills in biostatistics and bioinformatics, contributing to various research projects over several years.
Educational Background in Biostatistics and Bioinformatics
Richard Meier has a comprehensive academic background. He earned his Doctor of Philosophy (Ph.D.) in Biostatistics from the University of Kansas Medical Center, where he studied from 2014 to 2020. Prior to that, he studied Bioinformatics at Technische Fachhochschule Wildau, earning a Master's Degree from 2011 to 2015, and a Bachelor's Degree from 2008 to 2011.
Experience in Research Across Multiple Institutions
With over a decade of experience in research, Richard Meier has worked in various roles across different institutions. His career includes positions such as a Student Research Assistant at TH Wildau [FH] in Germany from 2010 to 2013. This international experience has enriched his skill set and provided him with a broad perspective in biostatistics and bioinformatics.
Background in Biostatistics and Bioinformatics
Richard Meier has a strong background in both biostatistics and bioinformatics. His extensive work experience and academic achievements in these fields enable him to contribute significantly to his current role at Bristol Myers Squibb. This dual expertise positions him well to address complex research questions and support the development of innovative solutions in the pharmaceutical industry.